BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38287048)

  • 1. Integrated blood and organ profile analysis to evaluate ameliorative effects of kaempferol on 5-fluorouracil-induced toxicity.
    Sharma A; Chorawala MR; Rawal RM; Shrivastava N
    Sci Rep; 2024 Jan; 14(1):2363. PubMed ID: 38287048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of kaempferol and 5‑fluorouracil on the growth of colorectal cancer cells by regulating the PI3K/Akt signaling pathway.
    Li Q; Wei L; Lin S; Chen Y; Lin J; Peng J
    Mol Med Rep; 2019 Jul; 20(1):728-734. PubMed ID: 31180555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Potential of Kaempferol against Sleep Deprivation-Induced Cognitive Impairment: Modulation of Neuroinflammation and Synaptic Plasticity Disruption in Mice.
    Du YY; Sun T; Yang Q; Liu QQ; Li JM; Yang L; Luo LX
    ACS Pharmacol Transl Sci; 2023 Dec; 6(12):1934-1944. PubMed ID: 38093836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis.
    Yao YX; Yu YJ; Dai S; Zhang CY; Xue XY; Zhou ML; Yao CH; Li YX
    Biomed Pharmacother; 2024 Jun; 175():116694. PubMed ID: 38713943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer.
    Zheng X; Yang X; Lin J; Song F; Shao Y
    Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring GATA3.
    Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W
    Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells.
    Riahi-Chebbi I; Souid S; Othman H; Haoues M; Karoui H; Morel A; Srairi-Abid N; Essafi M; Essafi-Benkhadir K
    Sci Rep; 2019 Jan; 9(1):195. PubMed ID: 30655588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5.
    Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX
    Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
    Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
    Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
    Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
    [No Abstract]   [Full Text] [Related]  

  • 11. Veliparib (ABT-888), a PARP inhibitor potentiates the cytotoxic activity of 5-fluorouracil by inhibiting MMR pathway through deregulation of MSH6 in colorectal cancer stem cells.
    Paul S; Chatterjee S; Sinha S; Dash SR; Pradhan R; Das B; Goutam K; Kundu CN
    Expert Opin Ther Targets; 2023; 27(10):999-1015. PubMed ID: 37787493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer.
    Zhang YZ; An JH; Liu YX; Wu XC; Han SS; Ren XQ; Qin CJ
    Cell Physiol Biochem; 2017; 43(3):1207-1219. PubMed ID: 28977800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10.
    Xie T; Geng J; Wang Y; Wang L; Huang M; Chen J; Zhang K; Xue L; Liu X; Mao X; Chen Y; Wang Q; Dai T; Ren L; Yu H; Wang R; Chen L; Chen C; Chu X
    Oncotarget; 2017 Jan; 8(5):8574-8589. PubMed ID: 28051999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA-producing Lactobacillus plantarum inhibits metastatic properties and induces apoptosis of 5-FU-resistant colorectal cancer cells via GABA
    An J; Seok H; Ha EM
    J Microbiol; 2021 Feb; 59(2):202-216. PubMed ID: 33527319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellagitannins from Pomegranate Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis in Rats while Enhancing Its Chemotoxicity against HT-29 Colorectal Cancer Cells through Intrinsic Apoptosis Induction.
    Chen XX; Lam KK; Feng YB; Xu K; Sze SC; Tang SC; Leung GP; Lee CK; Shi J; Yang ZJ; Li ST; Zhang ZJ; Zhang KY
    J Agric Food Chem; 2018 Jul; 66(27):7054-7064. PubMed ID: 29920075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer.
    Zhang S; Yang Y; Weng W; Guo B; Cai G; Ma Y; Cai S
    J Exp Clin Cancer Res; 2019 Jan; 38(1):14. PubMed ID: 30630498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.
    Vodenkova S; Buchler T; Cervena K; Veskrnova V; Vodicka P; Vymetalkova V
    Pharmacol Ther; 2020 Feb; 206():107447. PubMed ID: 31756363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside diphosphate kinase 2 confers acquired 5-fluorouracil resistance in colorectal cancer cells.
    Wen S; Wang X; Wang Y; Shen J; Pu J; Liang H; Chen C; Liu L; Dai P
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):896-905. PubMed ID: 29475390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariin-mediated inhibition of NF-κB activity enhances the in vitro and in vivo antitumour effect of 5-fluorouracil in colorectal cancer.
    Shi DB; Li XX; Zheng HT; Li DW; Cai GX; Peng JJ; Gu WL; Guan ZQ; Xu Y; Cai SJ
    Cell Biochem Biophys; 2014 Jul; 69(3):523-30. PubMed ID: 24435883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.